Related Experiment Video
Updated: Jul 17, 2026
07:14
Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice
Published on: May 23, 2025
Brain metastasis from cervical carcinoma.
J C Chura1, K Shukla, P A Argenta
1Department of Obstetrics, Gynecology, and Women's Health, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455, USA. chura004@umn.edu
Summary
Brain metastasis from cervical cancer is rare, often presenting with neurological symptoms. Whole-brain irradiation can improve symptoms, and chemotherapy after irradiation may extend survival.
Area of Science:
- Oncology
- Neurology
- Gynecologic Oncology
Background:
- Cervical cancer can metastasize to the brain, a rare but serious complication.
- Understanding the characteristics of brain metastasis from cervical cancer is crucial for patient management.
Purpose of the Study:
- To describe the clinical features, treatment, and survival outcomes of patients with brain metastasis secondary to cervical cancer.
Main Methods:
- Retrospective analysis of 12 patients diagnosed with brain metastasis from cervical cancer.
- Evaluation of patient demographics, initial cervical cancer stage, time to metastasis, symptoms, treatment modalities, and survival data.
Main Results:
- The incidence of brain metastasis was 0.77%. Most patients presented with neurological symptoms.
- Whole-brain irradiation with steroids improved symptoms in all treated patients.
- Median survival after brain metastasis diagnosis was poor (2.3 months), but chemotherapy post-irradiation showed a survival benefit (4.4 months vs. 0.9 months).
Conclusions:
- Brain metastasis from cervical cancer is associated with significant neurological sequelae and poor prognosis.
- Whole-brain irradiation is effective for symptom palliation.
- Chemotherapy following brain irradiation may improve survival in these patients.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...